4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002558
Chief Scientific Officer gave up 4,324 shares (to pay taxes)
- Chief Scientific Officer acquired 9,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Or Yat Sun Chief Scientific Officer | 2025-02-12 | Grant or award | +9,750 | 378,859 | D: show line 1 in the form | ||
| Or Yat Sun Chief Scientific Officer | 2025-02-12 | Shares withheld for taxes | −4,324 | $5.59 | $24,171 | 374,535 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…